Nutex Health (NASDAQ:NUTX) Trading 12.5% Higher – Still a Buy?

Nutex Health Inc. (NASDAQ:NUTX) shares were up 12.5% on Thursday . The stock traded as high as $165.00 and last traded at $165.3490. Approximately 84,551 shares changed hands during trading, a decline of 47% from the average daily volume of 160,024 shares. The stock had previously closed at $146.97.

Analyst Ratings Changes

NUTX has been the subject of several recent analyst reports. Wall Street Zen raised shares of Nutex Health from a “buy” rating to a “strong-buy” rating in a research note on Friday, November 28th. Weiss Ratings restated a “hold (c)” rating on shares of Nutex Health in a report on Monday, December 29th. Two investment analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $252.50.

Nutex Health Stock Performance

The company’s 50-day moving average price is $154.78 and its 200 day moving average price is $120.64. The stock has a market capitalization of $1.13 billion, a PE ratio of 8.62 and a beta of -0.08. The company has a debt-to-equity ratio of 0.67, a quick ratio of 3.18 and a current ratio of 3.20.

Nutex Health (NASDAQ:NUTX) last released its quarterly earnings results on Tuesday, November 18th. The company reported $7.76 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($5.43) by $13.19. The company had revenue of $243.99 million during the quarter, compared to the consensus estimate of $221.93 million. Nutex Health had a net margin of 11.62% and a return on equity of 37.44%.

Insider Activity at Nutex Health

In other news, CFO Jon Christian Bates purchased 750 shares of the company’s stock in a transaction that occurred on Tuesday, November 25th. The shares were bought at an average cost of $136.71 per share, for a total transaction of $102,532.50. Following the completion of the transaction, the chief financial officer directly owned 5,638 shares of the company’s stock, valued at $770,770.98. This trade represents a 15.34% increase in their position. The acquisition was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 36.92% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in NUTX. State of Alaska Department of Revenue purchased a new stake in shares of Nutex Health in the third quarter worth $30,000. BNP Paribas Financial Markets boosted its stake in Nutex Health by 966.7% in the 2nd quarter. BNP Paribas Financial Markets now owns 320 shares of the company’s stock worth $40,000 after purchasing an additional 290 shares in the last quarter. Ameritas Investment Partners Inc. purchased a new stake in Nutex Health during the 2nd quarter valued at about $44,000. Police & Firemen s Retirement System of New Jersey bought a new stake in Nutex Health during the 2nd quarter valued at about $97,000. Finally, KLP Kapitalforvaltning AS purchased a new position in Nutex Health in the second quarter worth about $112,000. Hedge funds and other institutional investors own 5.32% of the company’s stock.

Nutex Health Company Profile

Nutex Health, Inc (NASDAQ: NUTX) is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight‐loss services and behavioral health support. By combining in‐person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost‐effective treatment options outside traditional hospital settings.

The company’s urgent care network operates through both standalone and retail‐anchored centers, offering treatment for non‐life‐threatening injuries and illnesses, preventive screenings and basic primary care.